How Should a Company Account For Convertible Notes With Debt Issuance Costs or Placement Fees?

Misclassifying placement fees and other issuance costs on a convertible note can overstate expenses, understate liabilities, and delay an institutional raise. Under U.S. GAAP, these costs generally reduce the note's carrying value as a direct deduction from debt and amortize to interest expense over the note's term using the effective interest method. Convertible notes with bifurcated conversion features or fair value treatment may require different accounting, so review the instrument before finalizing the entry.

This matters before an institutional raise. Auditors and institutional diligence teams look at how a company has treated its existing debt. Issuance cost errors on a convertible note are a common finding during pre-raise financial reviews, and they can require restatements that slow or derail a round. Understanding how convertible note overhangs create downstream capital raise problems starts with getting the accounting right from the moment the note closes.

Why Debt Issuance Costs on Convertible Notes Require Specific Treatment

Convertible notes are debt instruments. That legal classification controls how the associated issuance costs are treated. Before 2015, companies had the option to record issuance costs as an asset on the balance sheet. The FASB eliminated that option with ASU 2015-03, which amended ASC 835-30 to require that debt issuance costs be presented as a deduction from the face amount of the related debt. The old asset treatment is no longer permitted under U.S. GAAP.

This means the carrying value of a convertible note on your balance sheet is the face amount of the note minus any unamortized issuance costs. That net figure is what appears as a liability. The gross principal is disclosed in the notes to the financial statements, but the balance sheet line shows the net carrying amount.

Two additional considerations apply specifically to convertible notes:

• ASC 470-20 bifurcation. If the convertible note has a beneficial conversion feature (BCF), the note may need to be bifurcated into a debt component and an equity component. When bifurcation applies, issuance costs are allocated between the two components based on their relative fair values at issuance. The portion allocated to the debt component reduces the carrying value of the note. The portion allocated to equity is recorded in additional paid-in capital. Note that for instruments issued after January 1, 2022, ASU 2020-06 eliminated the BCF model for most convertible instruments, so this bifurcation step may no longer apply depending on when the note was issued.
• ASC 815-15 embedded derivatives. If the conversion feature is required to be bifurcated as an embedded derivative under ASC 815-15, the accounting is more complex and typically requires a fair value election. In that case, issuance costs are generally expensed immediately rather than deferred. This is an exception to the standard ASC 835-30 treatment and requires careful analysis.

For most growth-stage convertible notes issued after 2022 without bifurcated derivatives, the treatment is straightforward: costs net against the note, amortize over the term.

Step-by-Step Accounting Treatment Under U.S. GAAP

Here is how to record and track debt issuance costs on a convertible note from issuance through the end of the note's life.

Step 1: Identify and total all qualifying issuance costs

At closing, gather every fee paid to get the note issued. This includes placement fees, legal fees paid to outside counsel for the note transaction, and advisory fees directly tied to the financing. Do not include general legal retainers, audit fees unrelated to the transaction, or internal staff costs. Only incremental, directly attributable costs qualify.

Step 2: Record the note net of issuance costs

On the issuance date, record the note as follows:

• Debit: Cash (proceeds received)
• Debit: Debt issuance costs contra-liability (reduces note carrying value)
• Credit: Convertible note payable (face amount)

The balance sheet will show the note at its net carrying value: face amount minus unamortized issuance costs.

Step 3: Amortize using the effective interest method

Each period, amortize a portion of the issuance costs to interest expense. The effective interest method calculates the amortization so that the carrying value of the note increases toward its face amount over the term. The effective interest rate is the rate that equates the present value of cash flows to the initial net proceeds. Straight-line amortization is only acceptable if the result is not materially different.

Step 4: Handle conversion or early repayment

If the note converts into equity, any unamortized issuance costs at the conversion date are written off. Under a plain contractual conversion, this write-off does not create a gain or loss. The unamortized costs reduce the carrying amount of the debt being extinguished, and the equity issued is recorded at that net amount. If the note is repaid early, unamortized issuance costs are expensed immediately as a loss on debt extinguishment under ASC 470-50.

Balance sheet presentation summary

What Placement Fees Include and How to Identify Them

Placement fees are the most common issuance cost on a growth-stage convertible note. They are fees paid to a broker-dealer, placement agent, or capital advisor for introducing investors or facilitating the note transaction. They are directly tied to the financing and qualify as debt issuance costs under ASC 835-30.

Not every fee paid around a note transaction is a placement fee. Here is how the three most common fee types are classified:

The key test is whether the fee would have been incurred without the specific note transaction. If the answer is yes, it is likely a general advisory cost and should be expensed. If the fee only exists because the note closed, it is a qualifying issuance cost.

Watch for fees paid in the form of warrants or equity. If a placement agent receives warrants as compensation, the fair value of those warrants at issuance is also a debt issuance cost. Record the fair value as a debit to the contra-liability and a credit to additional paid-in capital.

{{main-cta}}

How Misclassified Issuance Costs Affect Institutional Diligence

Institutional investors and their auditors review the balance sheet before they engage seriously on valuation. A misclassified issuance cost is not a rounding issue. It changes the carrying value of the note, the effective interest rate, and the interest expense reported in prior periods. Any of those errors can trigger a restatement request.

The three most common errors auditors flag are:

1. Immediate expensing. The company records the placement fee as an operating expense in the period it is paid. This overstates expenses in that period and understates the carrying value of the note going forward. The effective interest rate used for amortization is also wrong.
2. Capitalization to equity. The company records the fee as a debit to additional paid-in capital instead of netting it against the note. This is incorrect for a debt instrument and results in an overstated equity balance and an understated liability.
3. Incorrect netting. The company nets the costs against the note but uses straight-line amortization when the effective interest method produces a materially different result, or fails to accelerate the write-off at conversion.

Diligence teams look for consistency across periods. If the treatment in year one differs from year two without an accounting policy change or a disclosed correction, that inconsistency becomes a line of questioning. The financial model red flags that institutional diligence catches early include balance sheet items that do not reconcile cleanly to the underlying instruments.

Key point: A restatement of prior periods to correct issuance cost treatment delays a raise. It also signals to investors that the company's financial controls were not operating correctly. Getting the accounting right at issuance avoids this entirely.

What Happens When the Accounting Is Wrong: An Anonymized Example

A growth-stage technology company issued a $3M convertible note with a 24-month term. The placement agent received a 3% fee at closing, totaling $90,000. The company's bookkeeper recorded the fee as a general and administrative expense in the quarter the note closed.

When the company began preparing for a $20M Series B raise, the incoming auditors reviewed the prior two years of financials. They identified the misclassification immediately. The $90,000 should have been recorded as a contra-liability against the note and amortized to interest expense over 24 months at approximately $3,750 per month.

The correction required a restatement of two annual periods. Operating expenses in the original issuance quarter were overstated by $90,000. Interest expense in each subsequent quarter was understated. The note's carrying value on the balance sheet was also higher than it should have been because the contra-liability was never recorded.

The restatement took six weeks. The Series B timeline shifted. The lead investor required a management representation letter and an updated audit opinion before proceeding. The issue was correctable, but the delay and the additional scrutiny were preventable.

The accounting entry was simple. Getting it wrong cost six weeks and a restatement.

Clean Up the Accounting Before You Go to Market

If your company has outstanding convertible notes with associated fees, review the balance sheet treatment before investor outreach begins. The questions to answer are straightforward:

• Were the issuance costs recorded as a deduction from the note on the balance sheet?
• Is the amortization schedule using the effective interest method?
• If the note has already converted, were the unamortized costs written off correctly at conversion?
• Are the gross principal and unamortized costs disclosed in the footnotes?

If any answer is no, the financials need to be corrected before diligence begins. A proactive correction is a footnote disclosure. A correction that surfaces during diligence is a restatement with a timeline.

IRC Partners works with founders and CFOs preparing for institutional raises to identify structural and financial issues before investors do. The accounting treatment of existing debt is one of the first things an institutional diligence team reviews. If your capital stack includes convertible notes and you are preparing for a raise, understanding how capital stack issues affect your raise timeline is the right starting point. For a broader look at how debt advisory fits into a structured institutional raise, IRC Partners advises operators across the full capital stack.

Frequently Asked Questions

What is the difference between a debt issuance cost and a borrowing cost on a convertible note?

Debt issuance costs are the fees paid to get the note issued: placement fees, legal fees for the transaction, and advisory fees directly tied to the closing. Borrowing costs are the ongoing interest charges the company pays to the noteholder over the life of the instrument. Both reduce the company's cash, but they are recorded differently. Issuance costs net against the note on the balance sheet. Interest accrues as a liability and flows through the income statement as interest expense.

Does ASC 835-30 apply to all convertible notes, or only to certain types?

ASC 835-30 applies to all debt instruments, including convertible notes, unless the instrument is measured at fair value with changes recorded through earnings. If a company elects the fair value option for a convertible note, issuance costs are expensed immediately rather than deferred. For most growth-stage convertible notes without a fair value election, ASC 835-30 requires the costs to net against the carrying value of the note.

How does the effective interest method work for amortizing debt issuance costs?

The effective interest method calculates a constant rate of return on the net carrying value of the note over its term. At issuance, the net carrying value is the face amount minus unamortized issuance costs. Each period, the amortization amount increases slightly as the carrying value rises toward the face amount. The result is that interest expense, including amortized issuance costs, is higher in later periods than in earlier ones. This reflects the economics of the instrument more accurately than straight-line amortization.

What happens to unamortized debt issuance costs when a convertible note converts to equity?

When a convertible note converts under its original contractual terms, the unamortized issuance costs are written off as part of the conversion entry. The carrying value of the debt extinguished, which is the face amount minus the remaining unamortized costs, is transferred to equity. This write-off does not create a separate gain or loss on the income statement for a plain contractual conversion. The costs simply stop being deferred and become part of the equity consideration.

Can placement fees paid in warrants be treated as debt issuance costs?

Yes. If a placement agent receives warrants as compensation for facilitating the note transaction, the fair value of those warrants at the date of issuance is a debt issuance cost. The fair value is measured using an option pricing model. The entry debits the contra-liability account that nets against the note and credits additional paid-in capital. The warrant-based cost then amortizes to interest expense over the note term using the same effective interest method as cash fees.

How should a company disclose debt issuance costs in its financial statements?

The balance sheet presents the note at its net carrying value, which is the face amount minus unamortized issuance costs. The footnotes disclose the gross principal, the unamortized issuance cost balance, and the net carrying value separately. The income statement reflects amortization of issuance costs as a component of interest expense. The accounting policy note should describe the amortization method used. Consistent disclosure across periods is important because auditors and diligence teams compare footnote disclosures to the balance sheet line.

What should a CFO check before a Series A or Series B audit to confirm issuance costs are correctly recorded?

Pull the note agreement and every fee invoice paid at closing. Confirm the total qualifying costs are recorded as a contra-liability on the balance sheet, not as an asset or an expense. Verify the amortization schedule uses the effective interest method and that the periodic amortization amounts have been recorded consistently. If the note has already converted, confirm the unamortized balance was written off in the conversion period. Reconcile the footnote disclosure to the balance sheet line before the audit fieldwork begins.

Continue reading this series:

• Convertible Note Overhangs: Why Unresolved Notes From Your Seed Round Are a Series B Time Bomb
• How should founders negotiate a bridge financing round when an existing investor requests enhanced pro-rata rights
• How Capital Stack Strategy Advisory Works: 4 Stages

By the time most founders are rehearsing the pitch, the outcome of the raise has already been set by the structure underneath it. IRC Partners advises operators raising $5M to $250M of institutional capital and accepts seven strategic partners per quarter. If you are going to market this year, have the structure reviewed before investors do. Schedule a call with our team here.